{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:59:47Z","timestamp":1775685587640,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,2]],"date-time":"2027-02-02T00:00:00Z","timestamp":1801526400000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R42 CA224888"],"award-info":[{"award-number":["R42 CA224888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005713","name":"Office of the Secretary of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0297"],"award-info":[{"award-number":["W81XWH-20-1-0297"]}],"id":[{"id":"10.13039\/100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","award":["T32GM007205"],"award-info":[{"award-number":["T32GM007205"]}],"id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euo.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T15:11:16Z","timestamp":1739027476000},"page":"142-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies"],"prefix":"10.1016","volume":"9","author":[{"given":"Fuyao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Khajir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Leapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Sprenkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Spektor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffan","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Humphrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Staib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Onofrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.01.005_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.01.005_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamaoncol.2024.0734","article-title":"Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis","volume":"10","author":"Fazekas","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.01.005_b0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MOU.0b013e32835017fa","article-title":"Intraprostatic targeting","volume":"22","author":"Ukimura","year":"2012","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0030","first-page":"297","article-title":"Evaluating prostate needle biopsy: therapeutic and prognostic importance","volume":"47","author":"Bostwick","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.01.005_b0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.urology.2008.02.021","article-title":"Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen","volume":"72","author":"Isariyawongse","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.01.005_b0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.euo.2024.07.009","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted prostate biopsy: a systematic review and meta-analysis of prospective studies","volume":"7","author":"Zattoni","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.005_b0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.euo.2020.08.014","article-title":"Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)","volume":"4","author":"Falagario","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.005_b0050","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.eururo.2017.03.039","article-title":"Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer\u2014patient-tailored risk stratification can reduce unnecessary biopsies","volume":"72","author":"Radtke","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamaoncol.2017.5667","article-title":"A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification","volume":"4","author":"Mehralivand","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.01.005_b0060","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bju.13814","article-title":"A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy","volume":"120","author":"van Leeuwen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.005_b0065","doi-asserted-by":"crossref","unstructured":"Rustam Z, Darmawan NA, Hartini S, Aurelia JE. Support vector machines and na\u00efve Bayes classifier for classifying a prostate cancer. In: Kacprzyk J, Balas VE, Ezziyyani M, editors. Proceedings of Advanced Intelligent Systems for Sustainable Development (AI2SD 2020). Cham, Switzerland: Springer International Publishing; 2022. p. 854\u201360.","DOI":"10.1007\/978-3-030-90633-7_72"},{"key":"10.1016\/j.euo.2025.01.005_b0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4103\/1008-682X.186884","article-title":"Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen","volume":"19","author":"Xiao","year":"2017","journal-title":"Asian J Androl"},{"key":"10.1016\/j.euo.2025.01.005_b0075","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.21873\/anticanres.16967","article-title":"Machine-learning algorithm-based risk prediction and screening-detected prostate cancer in a benign prostate hyperplasia cohort","volume":"44","author":"Chang","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.euo.2025.01.005_b0080","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.euf.2021.11.009","article-title":"Advancing traditional prostate-specific antigen kinetics in the detection of prostate cancer: a machine learning model","volume":"8","author":"Perera","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.01.005_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/690787","article-title":"Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T","volume":"2014","author":"Citak-Er","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.euo.2025.01.005_b0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0090-4295(00)00672-5","article-title":"Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network","volume":"56","author":"Finne","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.01.005_b0095","article-title":"Prostate MRI and ultrasound with pathology and coordinates of tracked biopsy (Prostate-MRI-US-Biopsy) (version 2). Data set","author":"Natarajan","year":"2020","journal-title":"Cancer Imaging Archive"},{"key":"10.1016\/j.euo.2025.01.005_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.juro.2012.08.095","article-title":"Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device","volume":"189","author":"Sonn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0105","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","article-title":"The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository","volume":"26","author":"Clark","year":"2013","journal-title":"J Dig Imaging"},{"key":"10.1016\/j.euo.2025.01.005_b0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.01.005_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADSs v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.005_b0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.euo.2025.01.005_b0125","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.3390\/biomedicines11123309","article-title":"Inter-rater variability of prostate lesion segmentation on multiparametric prostate MRI","volume":"11","author":"Jeganathan","year":"2023","journal-title":"Biomedicines."},{"key":"10.1016\/j.euo.2025.01.005_b0130","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- versus high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.01.005_b0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/picr.PICR_87_17","article-title":"Common pitfalls in statistical analysis: logistic regression","volume":"8","author":"Ranganathan","year":"2017","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.euo.2025.01.005_b0140","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","article-title":"Logistic regression: a brief primer","volume":"18","author":"Stoltzfus","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.euo.2025.01.005_b0145","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/jnci\/djab062","article-title":"Association of health-care system with prostate cancer-specific mortality in African American and non-Hispanic white men","volume":"113","author":"Klebaner","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2025.01.005_b0150","first-page":"93","article-title":"Prostate biopsy: current status and limitations","volume":"9","author":"Presti","year":"2007","journal-title":"Rev Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:56:50Z","timestamp":1775681810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2588931125000264"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.005","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}